These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 16304961)

  • 1. [Antagonists: from physiology to assisted reproduction].
    Neuspiller F; Ayon P; Gallardo E
    Ginecol Obstet Mex; 2005 Jul; 73(7):378-86. PubMed ID: 16304961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GnRH antagonist in in vitro fertilization: where we are now.
    Shapiro DB; Mitchell-Leef D
    Minerva Ginecol; 2003 Oct; 55(5):373-88. PubMed ID: 14581880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of gonadotropin-releasing hormone antagonists in poor responders.
    Mahutte NG; Arici A
    Fertil Steril; 2007 Feb; 87(2):241-9. PubMed ID: 17113088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The use of GnRH antagonists in ovarian stimulation for intrauterine inseminations: is there any interest?].
    Pasquier M; Maitrot L; Leperlier F; Dehghani C; Snaifer E; Durnerin IC; Hugues JN
    Gynecol Obstet Fertil; 2008 Jun; 36(6):644-9. PubMed ID: 18539072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GnRH antagonists in ovarian stimulation for IVF.
    Tarlatzis BC; Fauser BC; Kolibianakis EM; Diedrich K; Rombauts L; Devroey P
    Hum Reprod Update; 2006; 12(4):333-40. PubMed ID: 16567347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of GnRH antagonists and flareup GnRH agonists in donor oocyte cycles.
    Wei AY; Mijal KA; Christianson MS; Schouweiler CM; Lindheim SR
    J Reprod Med; 2008 Mar; 53(3):147-50. PubMed ID: 18441715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New GnRH analogs in canine reproduction.
    Gobello C
    Anim Reprod Sci; 2007 Jul; 100(1-2):1-13. PubMed ID: 16979859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized controlled trial of increasing recombinant follicle-stimulating hormone after initiating a gonadotropin-releasing hormone antagonist for in vitro fertilization-embryo transfer.
    Propst AM; Bates GW; Robinson RD; Arthur NJ; Martin JE; Neal GS
    Fertil Steril; 2006 Jul; 86(1):58-63. PubMed ID: 16753156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeated in vitro fertilization cycle attempts in patients undergoing controlled ovarian hyperstimulation with use of gonadotropin-releasing hormone antagonists.
    Rabinson J; Ashkenazi J; Homburg R; Meltcer S; Anteby EY; Orvieto R
    Fertil Steril; 2009 Apr; 91(4 Suppl):1473-5. PubMed ID: 18937940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microdose gonadotropin-releasing hormone agonist flare-up protocol versus multiple dose gonadotropin-releasing hormone antagonist protocol in poor responders undergoing intracytoplasmic sperm injection-embryo transfer cycle.
    Kahraman K; Berker B; Atabekoglu CS; Sonmezer M; Cetinkaya E; Aytac R; Satiroglu H
    Fertil Steril; 2009 Jun; 91(6):2437-44. PubMed ID: 18555238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gonadotropin-releasing hormone (GnRH) antagonist plus recombinant luteinizing hormone vs. a standard GnRH agonist short protocol in patients at risk for poor ovarian response.
    De Placido G; Mollo A; Clarizia R; Strina I; Conforti S; Alviggi C
    Fertil Steril; 2006 Jan; 85(1):247-50. PubMed ID: 16412769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of gonadotropin-releasing hormone agonist/recombinant follicle-stimulating hormone versus gonadotropin-releasing hormone antagonist/recombinant follicle-stimulating hormone on follicular fluid levels of adhesion molecules during in vitro fertilization.
    Fornaro F; Cobellis L; Mele D; Tassou A; Badolati B; Sorrentino S; De Lucia D; Colacurci N
    Fertil Steril; 2007 Jan; 87(1):39-47. PubMed ID: 17084393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does the addition of a gonadotropin-releasing hormone agonist improve the pregnancy rate in intrauterine insemination? A prospective controlled trial.
    Eskandar MA
    Gynecol Endocrinol; 2007 Oct; 23(10):551-5. PubMed ID: 17891598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low AMH and GnRH-antagonist strategies.
    Nelson SM; Fleming R
    Fertil Steril; 2009 Aug; 92(2):e40; author reply e41. PubMed ID: 19580967
    [No Abstract]   [Full Text] [Related]  

  • 15. [Premature ovarian failure: which protocols?].
    Merviel P; Lourdel E; Boulard V; Cabry R; Claeys C; Oliéric MF; Sanguinet P; Brasseur F; Henri I; Copin H
    Gynecol Obstet Fertil; 2008 Sep; 36(9):872-81. PubMed ID: 18703373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [GnRH antagonists: yes or no?].
    Olivennes F; Fanchin R; Lédée N; Righini C; Frydman R
    Gynecol Obstet Fertil; 2000 Apr; 28(4):344-7. PubMed ID: 10859897
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of luteal estradiol patch and gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation versus microdose gonadotropin-releasing hormone agonist protocol for patients with a history of poor in vitro fertilization outcomes.
    Weitzman VN; Engmann L; DiLuigi A; Maier D; Nulsen J; Benadiva C
    Fertil Steril; 2009 Jul; 92(1):226-30. PubMed ID: 18675961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gonadotropin-releasing hormone antagonists do not influence the secretion of steroid hormones but affect the secretion of vascular endothelial growth factor from human granulosa luteinized cell cultures.
    Asimakopoulos B; Nikolettos N; Nehls B; Diedrich K; Al-Hasani S; Metzen E
    Fertil Steril; 2006 Sep; 86(3):636-41. PubMed ID: 16904114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GnRH antagonists in controlled ovarian hyperstimulation protocols in assisted reproductive technique programmes--current concepts.
    Jindal UN
    J Indian Med Assoc; 2006 Aug; 104(8):450, 452, 454 passim. PubMed ID: 17240802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gonadotropin-releasing hormone antagonist and metformin for treatment of polycystic ovary syndrome patients undergoing in vitro fertilization-embryo transfer.
    Doldi N; Persico P; Di Sebastiano F; Marsiglio E; Ferrari A
    Gynecol Endocrinol; 2006 May; 22(5):235-8. PubMed ID: 16785142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.